{
  "total_hcps": 100000,
  "segments": {
    "Dormant": {
      "count": 99222,
      "percentage": 99.22
    },
    "At-Risk": {
      "count": 613,
      "percentage": 0.61
    },
    "Need Attention": {
      "count": 158,
      "percentage": 0.16
    },
    "Potential": {
      "count": 5,
      "percentage": 0.01
    },
    "Champions": {
      "count": 1,
      "percentage": 0.0
    },
    "Loyal": {
      "count": 1,
      "percentage": 0.0
    }
  },
  "segment_characteristics": {
    "TRX(C13 Wk)": {
      "At-Risk": 8.2,
      "Champions": 1124.0,
      "Dormant": 4.3,
      "Loyal": 740.0,
      "Need Attention": 235.8,
      "Potential": 489.0
    },
    "TRXMktShare13": {
      "At-Risk": 14.46,
      "Champions": 100.0,
      "Dormant": 92.18,
      "Loyal": 100.0,
      "Need Attention": 95.12,
      "Potential": 99.0
    },
    "Calls13": {
      "At-Risk": 3.18,
      "Champions": NaN,
      "Dormant": 1.76,
      "Loyal": NaN,
      "Need Attention": NaN,
      "Potential": NaN
    },
    "Samples13": {
      "At-Risk": 25.68,
      "Champions": NaN,
      "Dormant": 16.84,
      "Loyal": NaN,
      "Need Attention": NaN,
      "Potential": NaN
    },
    "recency_days": {
      "At-Risk": 38.62,
      "Champions": NaN,
      "Dormant": 74.26,
      "Loyal": NaN,
      "Need Attention": NaN,
      "Potential": NaN
    }
  },
  "recommendations": [
    "Focus on 1 Champions - they drive most revenue",
    "Re-engage 613 At-Risk HCPs before they churn",
    "Win-back campaign needed for 99,222 Dormant HCPs"
  ],
  "decile_analysis": [
    {
      "decile": 1,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 10.0,
      "trx": 300659,
      "trx_pct": 63.6,
      "cumulative_trx_pct": 63.6,
      "avg_trx": 30.1,
      "calls": 812,
      "samples": 3664
    },
    {
      "decile": 2,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 20.0,
      "trx": 73825,
      "trx_pct": 15.6,
      "cumulative_trx_pct": 79.2,
      "avg_trx": 7.4,
      "calls": 589,
      "samples": 1272
    },
    {
      "decile": 3,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 30.0,
      "trx": 39392,
      "trx_pct": 8.3,
      "cumulative_trx_pct": 87.5,
      "avg_trx": 3.9,
      "calls": 478,
      "samples": 864
    },
    {
      "decile": 4,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 40.0,
      "trx": 24715,
      "trx_pct": 5.2,
      "cumulative_trx_pct": 92.7,
      "avg_trx": 2.5,
      "calls": 314,
      "samples": 856
    },
    {
      "decile": 5,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 50.0,
      "trx": 15522,
      "trx_pct": 3.3,
      "cumulative_trx_pct": 96.0,
      "avg_trx": 1.6,
      "calls": 279,
      "samples": 377
    },
    {
      "decile": 6,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 60.0,
      "trx": 10000,
      "trx_pct": 2.1,
      "cumulative_trx_pct": 98.1,
      "avg_trx": 1.0,
      "calls": 270,
      "samples": 236
    },
    {
      "decile": 7,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 70.0,
      "trx": 8808,
      "trx_pct": 1.9,
      "cumulative_trx_pct": 100.0,
      "avg_trx": 0.9,
      "calls": 222,
      "samples": 275
    },
    {
      "decile": 8,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 80.0,
      "trx": 0,
      "trx_pct": 0.0,
      "cumulative_trx_pct": 100.0,
      "avg_trx": 0.0,
      "calls": 141,
      "samples": 108
    },
    {
      "decile": 9,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 90.0,
      "trx": 0,
      "trx_pct": 0.0,
      "cumulative_trx_pct": 100.0,
      "avg_trx": 0.0,
      "calls": 116,
      "samples": 83
    },
    {
      "decile": 10,
      "hcp_count": 10000,
      "cumulative_hcps_pct": 100.0,
      "trx": 0,
      "trx_pct": 0.0,
      "cumulative_trx_pct": 100.0,
      "avg_trx": 0.0,
      "calls": 146,
      "samples": 87
    }
  ],
  "pareto_insights": {
    "top_10_pct_trx": 63.6,
    "top_20_pct_trx": 79.2,
    "top_50_pct_trx": 96.0
  },
  "pharma_standard_segments": {
    "Active Writer": {
      "count": 65306,
      "percentage": 65.31,
      "avg_trx_current": 7.14,
      "total_trx": 466231
    },
    "Potential Writer": {
      "count": 29630,
      "percentage": 29.63,
      "avg_trx_current": 0.0,
      "total_trx": 0
    },
    "Lapsed Writer": {
      "count": 4642,
      "percentage": 4.64,
      "avg_trx_current": 1.44,
      "total_trx": 6690
    },
    "Unaware Non-Writer": {
      "count": 225,
      "percentage": 0.22,
      "avg_trx_current": 0.0,
      "total_trx": 0
    },
    "Aware Non-Writer": {
      "count": 197,
      "percentage": 0.2,
      "avg_trx_current": 0.0,
      "total_trx": 0
    }
  },
  "pharma_cross_tab": {
    "Active Writer": {
      "At-Risk": 489,
      "Champions": 1,
      "Dormant": 64652,
      "Loyal": 1,
      "Need Attention": 158,
      "Potential": 5
    },
    "Aware Non-Writer": {
      "At-Risk": 44,
      "Champions": 0,
      "Dormant": 153,
      "Loyal": 0,
      "Need Attention": 0,
      "Potential": 0
    },
    "Lapsed Writer": {
      "At-Risk": 37,
      "Champions": 0,
      "Dormant": 4605,
      "Loyal": 0,
      "Need Attention": 0,
      "Potential": 0
    },
    "Potential Writer": {
      "At-Risk": 19,
      "Champions": 0,
      "Dormant": 29611,
      "Loyal": 0,
      "Need Attention": 0,
      "Potential": 0
    },
    "Unaware Non-Writer": {
      "At-Risk": 24,
      "Champions": 0,
      "Dormant": 201,
      "Loyal": 0,
      "Need Attention": 0,
      "Potential": 0
    }
  },
  "strategic_priorities": {
    "active_writers": 65306,
    "lapsed_writers": 4642,
    "potential_writers": 29630,
    "aware_non_writers": 197,
    "unaware_non_writers": 225
  }
}